Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2007
05/23/2007CN1968930A Bicyclic, nitrogen-containing heterocycles aromatase inhibitors
05/23/2007CN1968693A Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivative
05/23/2007CN1317280C Novel diazabicyclic aryl derivatives
05/23/2007CN1317267C Imide sulfo N-hydroxy maleopimarate as light acid producing agent and its synthetic method
05/22/2007US7220862 Calcitonin gene related peptide receptor antagonists
05/22/2007US7220861 Processes for preparing quinolonecarboxylate derivatives
05/22/2007US7220860 Anticancer agents
05/22/2007US7220859 For use in therapy
05/22/2007US7220857 Azo dye compound
05/22/2007US7220774 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators
05/22/2007US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis
05/22/2007US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties
05/22/2007US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis
05/22/2007US7220758 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
05/22/2007US7220757 Topically administering to the patient an antibacterially effective amount compounds such as N-(4,5-Dibromothien-2-ylmethyl)-N'-(1H-imidazo[4,5-b]pyridine-2-yl)-propane-1,3-diamine for therapy of bacterial infection
05/22/2007US7220756 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
05/22/2007US7220753 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors
05/22/2007US7220741 As cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters, for therapy of central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders
05/22/2007US7220740 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
05/22/2007US7220736 Pyrimidine compounds
05/22/2007US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion
05/22/2007CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds
05/22/2007CA2219692C S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
05/22/2007CA2157579C Heterocyclic compounds, their use and preparation
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2007056184A2 Azaindole compounds and use thereof as phospholipase-a2 inhibitors
05/18/2007WO2007056155A1 Heterocyclic compounds as tyrosine kinase modulators
05/18/2007WO2007056078A2 Certain chemical entities, compositions, and methods
05/18/2007WO2007054784A1 An improved process for the preparation of granisetron hydrochloride
05/18/2007WO2007054693A1 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
05/18/2007WO2007054556A1 Novel pyridopyrazines and their use as modulators of kinases
05/18/2007WO2007054508A1 Pyrrolopyridines as kinase inhibitors
05/18/2007WO2007054470A1 Use of rylene derivatives as photosensitizers in solar cells
05/18/2007WO2007054138A1 Substituted tetrahydroquinolines
05/18/2007WO2007034282A3 Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists
05/18/2007WO2007034278A3 Fused imidazole derivatives as c3a receptor antagonists
05/18/2007WO2007029037A3 Class iia histone deacetylase (hdac) substrate
05/18/2007WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007016029A3 Diazepinoquinolines, synthesis thereof, and intermediates thereto
05/18/2007WO2007002625A3 Compositions containing fluorine substituted olefins
05/18/2007WO2007002254A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
05/18/2007WO2006109085A8 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
05/18/2007CA2669736A1 Heterocyclic compounds as tyrosine kinase modulators
05/18/2007CA2629228A1 Pyrrolopyridines as kinase inhibitors
05/18/2007CA2628039A1 Novel pyridopyrazines and their use as modulators of kinases
05/18/2007CA2627349A1 Azaindole compounds and use thereof as phospholipase-a2 inhibitors
05/18/2007CA2627043A1 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
05/18/2007CA2611889A1 Substituted tetrahydroquinolines
05/17/2007US20070112021 Inhibiting gastric acid secretion
05/17/2007US20070112020 5Z)-2-(3-methylphenyl)-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)-3,5-dihydro-4H-imidazol-4-one; treating diseases linked to disregulated cell proliferation or to disregulated protein kinase
05/17/2007US20070112016 1-((tetrahydropyran-2-yl)oxy-ethyl)-5-tert-butoxycarbonyl-spiro[indoline-3,4'-piperidin]-2-one; ORL-1 (orphan opioid receptor) G-protein coupled receptor; brain, psychological disorders
05/17/2007US20070112015 Substituted dihydropyridines and methods of use
05/17/2007US20070112014 Therapeutic Compounds Based on Pyrazolopyridine
05/17/2007US20070112008 Saframycins, analogues and uses thereof
05/17/2007US20070112006 such as (7-methyl-5-trifluoromethyl-1,2,4-triazolo[1,5-a]pyrimidin-2-yl)-[3-(2-(N-methylaminocarbonyl)pyridin-4yloxy)phenyl]amine, used as tyrosine kinase inhibitors for the treatment of tumors
05/17/2007US20070111995 Pyrazolo [3,4-B] pyridine Compounds and Their Use as Phosphodiesterase Inhibitors
05/17/2007US20070111993 Pharmaceutical composition comprising a salt of mirtazapine
05/17/2007US20070111989 Novel diazabicyclononene derivatives and use
05/17/2007US20070111982 Calcitonin Gene-Related Peptide, CGRP; treatment of migraine and cluster headache; 2,5-dioxo-3',4'-dihydro-spiro(imidazolidine-4,2'(1'H)-naphthalene)-6'-carboxamides
05/16/2007EP1785425A2 Novel 1,4-diazabicycloalkane derivatives, their preparation and use
05/16/2007EP1785424A2 Fused 1,2,4-triazoles and pharmaceutical uses thereof
05/16/2007EP1785423A1 Pyridopyrazine derivatives and their use as kinase modulators
05/16/2007EP1785415A1 Piperidine derivative or pharmaceutically acceptable salt thereof
05/16/2007EP1784405A1 Determination of nucleic acid using electrocatalytic intercalators
05/16/2007EP1784404A1 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
05/16/2007EP1784403A1 Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
05/16/2007EP1784402A1 PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
05/16/2007EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
05/16/2007EP1784188A2 Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/16/2007EP1784187A2 Androgen receptor modulators
05/16/2007EP1784186A2 Methods for treating or preventing erectile dysfunction or urinary incontinence
05/16/2007EP1784185A2 Chemical compounds
05/16/2007EP1784180A2 2-amino 1h imidazo ring systems and methods
05/16/2007EP1784175A2 Inhibitors of akt activity
05/16/2007EP1434485B1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives for use as pesticides
05/16/2007EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/16/2007CN1964971A Amino-halogen-imidazopyridines as proton pump inhibitors
05/16/2007CN1964970A Iap的抑制剂 Iap inhibitors
05/16/2007CN1964969A Fused ring NK1 antagonists
05/16/2007CN1964968A 1-aza-bicyclo[3.3.1]nonanes
05/16/2007CN1964967A Lewis acid mediated synthesis of cyclic esters
05/16/2007CN1962660A Process for preparing photoresponsive azobenaene-perylene
05/16/2007CN1962659A 2- fluoro -N,N- dimethyl -2-(6-methyl-2-p-tolylimidazole [1,2-a] pyridine)-3- acetamide compound and its preparation method
05/16/2007CN1962658A Tetrahydropyridine [3,2-d] pyridine compound and its uses for preparing antineoplastic drug
05/16/2007CN1962641A Metalloproteinase inhibitors
05/16/2007CN1315829C Synthesis process of 1,7-disubstituent-3,4:9,10-perylene bisimide
05/16/2007CN1315828C Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates
05/16/2007CN1315827C 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
05/16/2007CN1315826C Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
05/16/2007CN1315825C Process for prodn. of naphthyridine carboxylic acid derivative (methanesulfonate sesquihydrate)
05/16/2007CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
05/15/2007US7217720 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; treatment of conditions caused by androgen deficiency
05/15/2007US7217719 1,3,8-Triaza-spiro[4.5]decan-2-one compounds, e.g., (4S)/(4R)-4-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-8-methyl-1,3,8-triaza-spiro [4.5]decan-2-one; treating schizophrenia, psychosis, migraine, hypertension, thrombosis, vasospasm, depression, anxiety, sleep and eating disorders
05/15/2007US7217717 Antiproliferation agents; anticancer agents; tyrosine kinase inhibitor
05/15/2007US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists
05/15/2007US7217709 Tetracyclic benzamide derivatives and methods of use thereof
05/15/2007US7217465 For use in light-emitting device; can be easily applied to vacuum vapor deposition and exhibit long wavelength light
05/15/2007CA2392973C Benzoimidazole derivatives useful as antiproliferative agents
05/15/2007CA2374767C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
05/10/2007WO2007053498A1 Compounds useful as antagonists of ccr2